What we do
The HealthTech Activator (HTA), developed by Callaghan Innovation and the Consortium for Medical Device Technologies (CMDT) with support from the Ministry of Business, Innovation and Employment (MBIE), is a dedicated initiative designed to empower New Zealand healthtech businesses. HTA provides streamlined access to funding, connectivity, and capability-building programmes to support innovators and early-stage businesses in the health technology sector. Aligned with the Ministry of Health's New Zealand Health Research Strategy 2017–2027, the HTA fosters transformative and innovative solutions that advance the health sector. By offering a comprehensive suite of resources and services, HTA aims to accelerate the success of healthtech businesses and contribute to improved healthcare outcomes across Aotearoa New Zealand.
Overview of our offering
- Tailored programmes and services: Access targeted support to meet the specific needs of healthtech businesses at various stages of their innovation journey.
- Funding opportunities: Streamline access to funding sources designed to help healthtech ventures grow and scale.
- Capability building: Enhance skills and expertise through training, mentorship, and access to specialised resources.
- Industry connectivity: Build networks with key stakeholders, including researchers, investors, and healthcare professionals.
- Alignment with health research strategy: Support transformative ideas aligned with the Ministry of Health’s New Zealand Health Research Strategy.
- Wraparound support: Benefit from comprehensive assistance, offering guidance and resources across all stages of innovation and development.
Target customer: Healthtech innovators, entrepreneurs, and early-stage businesses in New Zealand seeking guidance, resources, and support to develop and scale transformative healthcare technologies.